Ghostwriters, Data Manipulation and Dollar Diplomacy: How Drug Companies Pull the Strings in Clinical Research

Ann Emerg Med. 2008 Aug;52(2):137-9. doi: 10.1016/j.annemergmed.2008.06.009.

Publication types

  • News

MeSH terms

  • Authorship
  • Clinical Trials as Topic / economics*
  • Clinical Trials as Topic / ethics
  • Clinical Trials as Topic / legislation & jurisprudence
  • Clinical Trials as Topic / standards
  • Conflict of Interest / economics*
  • Cyclooxygenase 2 Inhibitors / adverse effects
  • Disclosure / standards
  • Drug Industry / economics*
  • Drug Industry / legislation & jurisprudence
  • Editorial Policies
  • Government Regulation
  • Lactones / adverse effects
  • Periodicals as Topic / standards
  • Publication Bias* / statistics & numerical data
  • Research Support as Topic* / ethics
  • Research Support as Topic* / legislation & jurisprudence
  • Research Support as Topic* / trends
  • Sulfones / adverse effects
  • United States

Substances

  • Cyclooxygenase 2 Inhibitors
  • Lactones
  • Sulfones
  • rofecoxib